Neuroscientific Biopharmaceuticals NSB
developing novel peptide-based pharmaceutical products that target a number of neurological disorders such as Alzheimers, Dementia, Multiple Sclerosis and even eye diseases like Glaucoma.
MCAP 19.6M
SOI only 78M with top 20 holding 60.19%
Cash in bank $3.28M
https://www.barchart.com/stocks/quotes/NSB.AX/opinion
gives NSB a 100% 'Buy rating' across all technical chart indicators
DYOR .. Cheers tela
- Forums
- ASX - Day Trading
- Day trading pre-market open September 3
Day trading pre-market open September 3, page-100
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)